Yonghyun (John) Kim

Prof. Yonghyun (John) Kim

The University of Alabama
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2012 in Cancer Research
Verified
Journal Article
Closed access
PDF file
Kyeung Min JooKyeung Min Joo
Kyeung Min Joo
JJJuyoun Jin
Juyoun Jin
EKEunhee Kim
Eunhee Kim
KKKang Ho Kim
Kang Ho Kim
Yonghyun (John) KimYonghyun (John) Kim
Yonghyun (John) Kim
DNDo-Hyun Nam
Do-Hyun Nam
Glioblastomas multiforme (GBM) contain highly tumorigenic, self-renewing populations of stem/initiating cells [glioblastoma stem cells (GSC)] that contribute to tumor propagation and treatment resistance. However, our knowledge of the specific signaling pathways that regulate GSCs is limited. The MET tyrosine kinase is known to stimulate the survival, proliferation, and invasion of various cancers including GBM. Here, we identified a distinct fraction of cells expressing a high level of MET in human primary GBM specimens that were preferentially localized in perivascular regions of human GBM biopsy tissues and were found to be highly clonogenic, tumorigenic, and resistant to radiation. Inhibition of MET signaling in GSCs disrupted tumor growth and invasiveness both in vitro and in vivo, suggesting that MET activation is required for GSCs. Together, our findings indicate that MET activation in GBM is a functional requisite for the cancer stem cell phenotype and a promising therapeutic target. Cancer Res; 72(15); 3828–38. ©2012 AACR.

1 March 2012 in Laboratory Investigation
Verified
Journal Article
Closed access
Yonghyun (John) KimYonghyun (John) Kim
Yonghyun (John) Kim
KKKang Ho Kim
Kang Ho Kim
JLJeena Lee
Jeena Lee
YLYoung-Ae Lee
Young-Ae Lee
MKMisuk Kim
Misuk Kim
DNDo-Hyun Nam
Do-Hyun Nam

1 September 2007 in Trends in Biotechnology
Verified
Journal Article
Closed access
Yonghyun (John) KimYonghyun (John) Kim
Yonghyun (John) Kim
MNM.P. Nandakumar
M.P. Nandakumar
MMMark Marten
Mark Marten

9 November 2011 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
JJJuyoun Jin
Juyoun Jin
Ki Hyun BaeKi Hyun Bae
Ki Hyun Bae
HYHeekyoung Yang
Heekyoung Yang
SLSe Jeong Lee
Se Jeong Lee
HKHyein Kim
Hyein Kim
DNDo-Hyun Nam
Do-Hyun Nam

18 May 2017 in Biofabrication
Verified
Journal Article
Closed access
PDF file
AQAnisa S Qayyum
Anisa S Qayyum
Era JainEra Jain
Era Jain
GKGrant Kolar
Grant Kolar
Yonghyun (John) KimYonghyun (John) Kim
Yonghyun (John) Kim
SSScott A Sell
Scott A Sell
Silviya ZustiakSilviya Zustiak
Silviya Zustiak
Electrohydrodynamic spraying (EHS) has recently gained popularity for microencapsulation of cells for applications in cell delivery and tissue engineering. Some of the polymers compatible with EHS are alginate, chitosan, and other similar natural polymers, which are subject to ionotropic or physical gelation. It is desirable to further extend the use of the EHS technique beyond such polymers for wider biofabrication applications. Here, building upon our previous work of making PEG microspheres via EHS, we utilized the principles of EHS to fabricate cell-laden polyethylene glycol (PEG) hydrogel microspheres. The gelation of PEG hydrogel microspheres was achieved by forming covalent crosslinks between multiarm PEG acrylate and dithiol crosslinkers via Michael-type addition. We conducted a detailed investigation of the critical parameters of EHS, such as the applied voltage, inner needle diameter (i.d. needle), and flow rate, to obtain PEG microspheres with high cell viability and tightly-controlled diameters in the range of 70–300 μ m. The polydispersity of cell-laden PEG hydrogel microspheres as measured by % coefficient of variation was between 6% and 23% for all conditions tested. We established that our method was compatible with different cell types and that all tested cell types could be encapsulated at high densities of 10 6 –10 9 and ≥90% encapsulation efficiency. We observed cell aggregation within the hydrogel microspheres at applied voltage >5 kV. Since PEG is a synthetic polymer devoid of cell attachment sites, we could overcome this limitation by tethering Arg-Gly-Asp-Ser (RGDS) peptide to the PEG hydrogel microspheres; upon RGDS tethering, we observed uniform cell dispersion. The microencapsulated cells could be cultured in the PEG hydrogel microspheres of different sizes for up to one week without significant loss in cell viability. In conclusion, the EHS technique developed here could be used to generate cell-laden PEG hydrogel microspheres of controlled sizes for potential applications in cell delivery and organoid cultures.

31 May 2009 in International Journal of Stem Cells
Verified
Journal Article
Open access
Yonghyun (John) KimYonghyun (John) Kim
Yonghyun (John) Kim
Kyeung Min JooKyeung Min Joo
Kyeung Min Joo
JJJuyoun Jin
Juyoun Jin
DNDo-Hyun Nam
Do-Hyun Nam
The advent of cancer stem cell (CSC) hypothesis has revolutionized the cancer biology community's thinking in explaining the notorious resistance of cancer to conventional chemo- and radiotherapies. The hypothesis states that the CSCs are a subpopulation within the tumor endowed with superior resistance and with the exclusive ability to self-renew, differentiate into diverse type of progeny cancer cells, and initiate tumor. Here, we review recent literature that seek out to explain such resistance of CSCs. Signaling pathways involved in the regulation of proliferation and differentiation of stem cells (e.g. Notch, Hh, and Wnt) and efficient ABC transporter systems and DNA damage response machineries are starting to be identified as the means by which CSCs out-survive their non-CSC neighbors after conventional anti-cancer treatments. Direct links between receptor tyrosine kinase pathways and CSCs are also starting to emerge as well. Lastly, a promising relationship between epithelial-mesenchymal transition and CSCs is discussed. Though the precise resistance pathway of CSCs is not yet fully elucidated, the various mechanisms highlighted here provide promise for better fundamental understanding of CSCs and the subsequent development of a more effective CSC-targeting therapeutic in the foreseeable future.